WO2003017991A3 - Injection solution containing a dihydropyridin derivative - Google Patents

Injection solution containing a dihydropyridin derivative Download PDF

Info

Publication number
WO2003017991A3
WO2003017991A3 PCT/EP2002/009778 EP0209778W WO03017991A3 WO 2003017991 A3 WO2003017991 A3 WO 2003017991A3 EP 0209778 W EP0209778 W EP 0209778W WO 03017991 A3 WO03017991 A3 WO 03017991A3
Authority
WO
WIPO (PCT)
Prior art keywords
dihydropyridin
derivative
solution containing
injection solution
derivatives
Prior art date
Application number
PCT/EP2002/009778
Other languages
German (de)
French (fr)
Other versions
WO2003017991A2 (en
Inventor
Ralph E Eckert
Original Assignee
Molecular And Clinical Drug Re
Ralph E Eckert
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Molecular And Clinical Drug Re, Ralph E Eckert filed Critical Molecular And Clinical Drug Re
Priority to AU2002331101A priority Critical patent/AU2002331101A1/en
Publication of WO2003017991A2 publication Critical patent/WO2003017991A2/en
Publication of WO2003017991A3 publication Critical patent/WO2003017991A3/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4422—1,4-Dihydropyridines, e.g. nifedipine, nicardipine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Dermatology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

The invention relates to a drug containing an aqueous formulation of dihydropyridin derivatives with at least one water-miscible solubilizer.
PCT/EP2002/009778 2001-08-31 2002-09-02 Injection solution containing a dihydropyridin derivative WO2003017991A2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU2002331101A AU2002331101A1 (en) 2001-08-31 2002-09-02 Injection solution containing a dihydropyridin derivative

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10142417A DE10142417A1 (en) 2001-08-31 2001-08-31 drug
DE10142417.5 2001-08-31

Publications (2)

Publication Number Publication Date
WO2003017991A2 WO2003017991A2 (en) 2003-03-06
WO2003017991A3 true WO2003017991A3 (en) 2003-12-04

Family

ID=7697054

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP2002/009778 WO2003017991A2 (en) 2001-08-31 2002-09-02 Injection solution containing a dihydropyridin derivative

Country Status (3)

Country Link
AU (1) AU2002331101A1 (en)
DE (1) DE10142417A1 (en)
WO (1) WO2003017991A2 (en)

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0315960A1 (en) * 1987-11-11 1989-05-17 Euro-Celtique S.A. Instant oral-release capsule containing nifedipine
US4880623A (en) * 1985-10-15 1989-11-14 Eurand Italia S.P.A. Process for the preparation of solid nifedipine formulations of high bioavailability and with sustained effect, and formulations thus obtained

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2815578C2 (en) * 1978-04-11 1986-01-16 Bayer Ag, 5090 Leverkusen New pharmaceutical use of nimodipine
DE3307422A1 (en) * 1983-03-03 1984-09-06 Bayer Ag, 5090 Leverkusen LIQUID PREPARATIONS OF DIHYDROPYRIDINES, A METHOD FOR THE PRODUCTION THEREOF AND THEIR USE IN THE FIGHT AGAINST DISEASES
DE3315805A1 (en) * 1983-04-30 1984-11-08 Bayer Ag, 5090 Leverkusen Active substance compositions
DE3316510A1 (en) * 1983-05-06 1984-11-08 Bayer Ag PARENTERAL FORMULATION OF NIMODIPIN, A METHOD FOR THE PRODUCTION THEREOF AND THEIR USE IN THE FIGHT AGAINST DISEASES
EP0175671A1 (en) * 1984-08-23 1986-03-26 Kuhlemann & Co. Pharmaceutical preparation and method for the administration of this pharmaceutical preparation
DE3544692A1 (en) * 1985-12-18 1987-06-19 Bayer Ag DIHYDROPYRIDINE SPRAY, METHOD FOR THE PRODUCTION THEREOF AND ITS PHARMACEUTICAL USE
ES2119748T3 (en) * 1990-03-23 1998-10-16 Yoshitomi Pharmaceutical PHARMACEUTICAL COMPOSITION CONTAINING A PHARMACEUTICALLY SOLUBLE IN WATER.

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4880623A (en) * 1985-10-15 1989-11-14 Eurand Italia S.P.A. Process for the preparation of solid nifedipine formulations of high bioavailability and with sustained effect, and formulations thus obtained
EP0315960A1 (en) * 1987-11-11 1989-05-17 Euro-Celtique S.A. Instant oral-release capsule containing nifedipine

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
DATABASE BIOSIS [online] BIOSCIENCES INFORMATION SERVICE, PHILADELPHIA, PA, US; 1997, CHEN GUI-LIN WANG QIAO ET AL.: "PREPARATION OF NIMODIPINE INJECTION OF HIGHER CONCENTRATION", XP002233651, Database accession no. PREV199799804897 *
DATABASE EMBASE [online] ELSEVIER SCIENCE PUBLISHERS, AMSTERDAM, NL; 1997, SARIKAYA ET AL: "EFFECTS OF INTRACAVERNOUS CALCIUM CHANNEL BLOCKERS IN DOGS", XP002233652, Database accession no. EMB-1998035215 *
INTERNATIONAL UROLOGY AND NEPHROLOGY, vol. 29, no. 6, 1997, pages 673 - 680, ISSN: 0301-1623 *
ZHONGGUO YIYAO GONGYE ZAZHI, vol. 28, no. 6, 1997, pages 254 - 256, ISSN: 1001-8255 *

Also Published As

Publication number Publication date
DE10142417A1 (en) 2003-03-20
WO2003017991A2 (en) 2003-03-06
AU2002331101A1 (en) 2003-03-10

Similar Documents

Publication Publication Date Title
NO20034149D0 (en) Medicines containing triazaspiro [5.5] undecane derivatives as the active ingredient
MA26936A1 (en) 3-INDOLYL-4 PHENYL-1H-PYRROLE-2,5-DIONE DERIVATIVES AS GLYCOGENE SYNTHASE KINASE-3 BETA INHIBITORS
AU5722800A (en) Imidazoline derivatives for the treatment of diabetes, especially type ii diabetes
WO2003035617A3 (en) Derivatives of uk-2a
AU2001290250A1 (en) Ep4 receptor agonists containing 8-azaprostaglandin derivatives as the active ingredient
AU2001267766A1 (en) Pyrazole derivatives
AU2001235691A1 (en) Use of paullone derivatives for making medicines
AU2001278771A1 (en) Carboxylic acid derivatives, process for producing the same and drugs containingthe same as the active ingredient
AU2002226674A1 (en) Tricyclic and heterocyclic derivative compounds and drugs containing these compounds as the active ingredient
EP1295879A4 (en) Medicinal compositions containing propenone derivatives
DE69813496D1 (en) Cyclodextrin composition containing an avermectin or a milbemycin derivative
AU2001226794A1 (en) Substituted 1,2,3,4- tetrahydroquinoline-2-carboxylic acid derivatives
HK1052007A1 (en) Novel heterocyclic derivatives, preparation methodand pharmaceutical compositions containing same.
WO2003024933A1 (en) 2-phenyl-3-heteroarylpropionic acid derivative or salt thereof and medicine containing the same
WO2004004639A3 (en) A novel stable formulation
AU2002352357A1 (en) Trioxane derivatives
AU2001292122A1 (en) Heterocyclic derivatives useful as pharmaceutical agents
AU2002241211A1 (en) Imidazo-triazine derivatives as pde 5 inhibitors
WO2002076376A3 (en) A stable pharmaceutical composition of pravastatin
AU2002350942A1 (en) Imidazolidineacetic acid derivatives
WO2003017991A3 (en) Injection solution containing a dihydropyridin derivative
WO2004048381A3 (en) Pyrazoloazepine compounds as pharmaceutical agents
AU2001234189A1 (en) Vitamin d derivatives having substituents at the 2alpha-position
WO2000076966A3 (en) Indolinylamide derivatives and the use thereof as antiviral drugs
AU2154901A (en) Simplified administration of alpha-lipoic acid or derivatives thereof

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BY BZ CA CH CN CO CR CU CZ DE DM DZ EC EE ES FI GB GD GE GH HR HU ID IL IN IS JP KE KG KP KR LC LK LR LS LT LU LV MA MD MG MN MW MX MZ NO NZ OM PH PL PT RU SD SE SG SI SK SL TJ TM TN TR TZ UA UG US UZ VC VN YU ZA ZM

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ OM PH PL PT RO RU SD SE SG SI SK SL TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR IE IT LU MC NL PT SE SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ UG ZM ZW AM AZ BY KG KZ RU TJ TM AT BE BG CH CY CZ DK EE ES FI FR GB GR IE IT LU MC PT SE SK TR BF BJ CF CG CI GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase

Ref country code: JP

WWW Wipo information: withdrawn in national office

Country of ref document: JP